Vonovia Traders Face Two Clocks: Berlin's Expropriation Timetable and the November Numbers
Bitcoin Cash price stands at 278.41 USD as futures contracts trade
Jeff Yan's 500,000 HYPE proposal: What it means for the Hyperliquid price
Siemens Energy: Barclays Flags Pricing Risk as GE Vernova Contagion Drives a 2.9% Decline
SoftBank Wipes Out 2.875% Euro Note Early as Credit Markets Turn a Harder Eye on Its AI Spending
Micron's Friday Rebound Came From the Sector — Its Own Headlines Are Still Unresolved
CATL's 7.8% Rebound Meets a Harder Question: Where Is the Profit?
Evotec's Ownership Shake-Up and Analyst Caution Point to the Same Date: November 5
Lenzing Insiders Take Stock at EUR 8.65 as Heiligenkreuz Closure Slips to Early 2027
Commerzbank: Two Verdicts Loom — the Third-Quarter Ledger and the Terms of UniCredit's Advance
Rheinmetall's Factory Floors Are Humming. The Analysts Are Trimming Their Targets Anyway
Moderna's Melanoma Shot Works. The Question Is Whether It Can Be Manufactured Into a Business
AST SpaceMobile's Countdown to Service Runs Through Ground Infrastructure, Not a Price Target
A Gift, a Target Hike and a Polish Push: Reading Berkshire's Week Without the Noise
Evonik's Ashland Option Predates BASF's Courtship — and That Changes the Calculus
SanDisk's Two-Pronged Story: Firm NAND Pricing Into 2027 and an Exclusive Meta Role
BYD's Technology Roadmap and Brazil Expansion Face a Reckoning on October 29
Rolls-Royce's Free Service Upgrade Meets a Sector That Just Got More Skeptical
Bloom Energy's Record Quarter Exposes the Funding Side of Its Growth Story
Nvidia's Cheap Multiple Is Only Half the Story
Infineon's Supply-Chain Groundwork Cuts Through the AI Noise
Allianz Redraws Its Sales Map and Home Cover as Broker Targets Diverge
Deutz Confidence Is Cheap. Proof Costs More.
Xiaomi's NĂĽrburgring Base and RMB 200 Billion R&D Pledge Sharpen Its Auto Bet
ASML's Order Book Is Full. Its Supply Chain Is the Open Question.
Wienerberger Pushes a New Clay Facade Tile While UBS Lifts Its Reported Holding to 4.49%
Bayer's Kidney Portfolio Delivers on Two Fronts as Wall Street Waits for November Numbers
Commerzbank: Labour Voices Demand a Fair Price as Barclays Steps Back